Puma Biotechnology, Inc. (PBYI)

Puma Biotechnology Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	238.06	230.47	235.64	228.03	253.16	225.11
Revenue Growth (YoY)	8.63%	-2.19%	3.34%	-9.92%	12.46%	-17.32%
Cost of Revenue	65.88	64.4	62.68	55.09	63.7	39.37
Gross Profit	172.19	166.06	172.96	172.94	189.45	185.74
Selling, General & Admin	69.09	80.16	89.93	89.98	116.29	118.49
Research & Development	57.03	54.94	50.38	59.24	71.87	97.65
Total Operating Expenses	126.12	135.1	140.32	149.22	188.16	216.14
Operating Income	46.06	30.97	32.64	23.72	1.29	-30.4
Interest Income	4.57	4.72	2.61	0.81	0.16	0.49
Interest Expense	-9.74	-12.45	-13.33	-11.59	-12.81	-14.05
Other Non-Operating Income (Expense)	1.38	0.86	0.76	-12.48	-17.45	-15.83
Total Non-Operating Income (Expense)	-3.79	-6.87	-9.97	-23.26	-30.09	-29.39
Pretax Income	42.28	24.1	22.67	0.46	-28.8	-59.79
Provision for Income Taxes	0.9	0.9	1.08	0.46	0.32	0.21
Net Income	48.45	30.28	21.59	0	-29.13	-60
Net Income to Common	48.45	30.28	21.59	0	-29.13	-60
Net Income Growth	455.63%	40.23%	1079450.00%	-	-	-
Shares Outstanding (Basic)	49	49	47	45	41	40
Shares Outstanding (Diluted)	50	49	48	45	41	40
Shares Change (YoY)	3.24%	3.26%	5.83%	10.56%	2.69%	2.08%
EPS (Basic)	0.98	0.62	0.46	0.00	-0.72	-1.52
EPS (Diluted)	0.99	0.62	0.45	0.00	-0.72	-1.52
EPS Growth	450.00%	37.78%	1010824.96%	-	-	-
Free Cash Flow	44.22	38.86	26.87	-15.83	20.65	0.73
Free Cash Flow Growth	13.79%	44.64%	-	-	2740.44%	-96.71%
Free Cash Flow Per Share	0.89	0.79	0.57	-0.35	0.51	0.02
Gross Margin	72.33%	72.06%	73.40%	75.84%	74.84%	82.51%
Operating Margin	19.35%	13.44%	13.85%	10.40%	0.51%	-13.51%
Profit Margin	17.38%	10.07%	9.16%	0.00%	-11.51%	-26.65%
FCF Margin	18.58%	16.86%	11.40%	-6.94%	8.16%	0.32%
EBITDA	57.34	42.49	44.16	33.56	12.6	-20.37
EBITDA Margin	24.09%	18.44%	18.74%	14.72%	4.98%	-9.05%
EBIT	46.06	30.97	32.64	23.72	1.29	-30.4
EBIT Margin	19.35%	13.44%	13.85%	10.40%	0.51%	-13.51%
Effective Tax Rate	2.13%	3.72%	4.78%	99.56%	-1.12%	-0.35%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q